Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
| Role | Insider | Date | Transaction | Value | Shares |
|---|---|---|---|---|---|
| Director | Milligan Sandra | Aug 19, 2025 | Buy | $50.02K | 26,050 |
| Chief Medical Officer | Aranda Richard | Jun 24, 2024 | Sell | $1.26K | 1,908 |
| CEO | Hasnain Faheem | Jun 21, 2024 | Buy | $250.28K | 372,000 |
| CFO | Giraudo Bryan | Jun 18, 2024 | Buy | $59.11K | 100,000 |
| Chief Commercial Officer | Smith Robert Paul JR | Jun 17, 2024 | Buy | $15.05K | 25,000 |
| EVP, Tech Ops and Admin | Christian Waage | Mar 27, 2024 | Sell | $7.43K | 6,430 |
| CEO | Hasnain Faheem | Mar 27, 2024 | Sell | $26.77K | 23,172 |
| CFO | Giraudo Bryan | Mar 27, 2024 | Sell | $7.43K | 6,430 |
| EVP, Regulatory Affairs | Peterson Caryn | Mar 18, 2024 | Sell | $5.34K | 4,018 |
| Chief Medical Officer | Aranda Richard | Mar 18, 2024 | Sell | $5.34K | 4,018 |
| Director | Milligan Sandra | Nov 15, 2023 | Buy | $25.21K | 32,000 |
| CFO | Giraudo Bryan | Nov 13, 2023 | Buy | $112.88K | 200,000 |
| Chief Medical Officer | Aranda Richard | Jun 22, 2023 | Sell | $2.34K | 1,814 |
| CFO | Giraudo Bryan | Apr 4, 2023 | Buy | $56.09K | 55,000 |
| CEO | Hasnain Faheem | Mar 22, 2023 | Buy | $503.58K | 440,500 |
| CEO | Hasnain Faheem | Mar 21, 2023 | Buy | $322.32K | 269,389 |
| CFO | Giraudo Bryan | Mar 20, 2023 | Buy | $48.44K | 50,000 |
| CEO | Hasnain Faheem | Mar 20, 2023 | Buy | $174.49K | 168,683 |
| EVP, Tech Ops and Admin | Christian Waage | Mar 20, 2023 | Buy | $22.14K | 18,500 |
| Chief Scientific Officer | Carter Laura | Mar 16, 2023 | Sell | $6.62K | 6,029 |
| Chief Medical Officer | Aranda Richard | Mar 16, 2023 | Sell | $8.3K | 7,563 |
| EVP, Regulatory Affairs | Peterson Caryn | Mar 16, 2023 | Sell | $8.31K | 7,564 |
| Chief Medical Officer | Aranda Richard | Oct 24, 2022 | Sell | $57.43K | 4,757 |
| EVP, Regulatory Affairs | Peterson Caryn | Oct 24, 2022 | Sell | $57.43K | 4,757 |
| Chief Scientific Officer | Carter Laura | Oct 24, 2022 | Sell | $58.87K | 4,876 |
Open-market purchases and sales reported on SEC form 4 over the last 10years. Awards, option exercises, gifts and other non-market form 4 activity are excluded. Chart markers group a day's filings by direction; the table lists each filing.
